Literature DB >> 9276087

Monoclonal antibodies reactive with human osteogenic cell surface antigens.

S P Bruder1, M C Horowitz, J D Mosca, S E Haynesworth.   

Abstract

Monoclonal antibodies (McAbs) against the surface of osteoblastic cells have been used to characterize the osteogenic lineage. In view of the paucity of probes against the surface of normal human osteogenic cells, we sought to generate McAbs which could be used for both in vivo and in vitro studies. We raised a series of McAbs against early osteoblastic cell surface antigens by immunizing mice with human mesenchymal stem cells (MSCs) that had been directed into the osteogenic lineage in vitro. After screening against the surface of osteogenic cells at various stages of differentiation in vitro, as well as evaluating in situ reactivity with human fetal limbs, we isolated three hybridoma cell lines referred to as SB-10, SB-20, and SB-21. Immunocytochemical analyses during osteogenic differentiation demonstrate that SB-10 reacts with MSCs and osteoprogenitors, but no longer reacts with cells once alkaline phosphatase (APase) is expressed. Flow cytometry documents that SB-10 is expressed on the surface of all purified, culture-expanded human MSCs, thus providing further evidence that these cells are a homogeneous population. By contrast, SB-20 and SB-21 do not react with the progenitor cells in situ, but bind to a subset of the APase-positive osteoblasts. None of these antibodies stain terminally differentiated osteocytes in sections of developing bone. Furthermore, these McAbs were not observed to react in samples from chick, rat, rabbit, canine, or bovine bone, although selected extraskeletal human tissues were immunostained. In all cell and tissue specimens examined, SB-20 immunostaining is identical to that observed with SB-21. We have used these McAbs to refine our understanding of the discrete cellular transitions that constitute the osteogenic cell lineage. We suggest a refined model for understanding osteoblast differentiation that is based on the proposition that the sequential acquisition and loss of specific cell surface molecules can be used to define positions of individual cells within the osteogenic cell lineage.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9276087     DOI: 10.1016/s8756-3282(97)00127-0

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  18 in total

1.  In vitro and in vivo methods to determine the interactions of osteogenic cells with biomaterials.

Authors:  R O Oreffo; J T Triffitt
Journal:  J Mater Sci Mater Med       Date:  1999 Oct-Nov       Impact factor: 3.896

Review 2.  Mesenchymal stem cells: lineage, plasticity, and skeletal therapeutic potential.

Authors:  Richard O C Oreffo; Cyrus Cooper; Christopher Mason; Mark Clements
Journal:  Stem Cell Rev       Date:  2005       Impact factor: 5.739

3.  Use of an alpha-smooth muscle actin GFP reporter to identify an osteoprogenitor population.

Authors:  Zana Kalajzic; Haitao Li; Li-Ping Wang; Xi Jiang; Katie Lamothe; Douglas J Adams; Hector L Aguila; David W Rowe; Ivo Kalajzic
Journal:  Bone       Date:  2008-05-10       Impact factor: 4.398

4.  In vitro Differentiation Potential of Mesenchymal Stem Cells.

Authors:  Jeffrey M Gimble; Farshid Guilak; Mark E Nuttall; Solomon Sathishkumar; Martin Vidal; Bruce A Bunnell
Journal:  Transfus Med Hemother       Date:  2008-05-08       Impact factor: 3.747

5.  Development of novel monoclonal antibodies that define differentiation stages of human stromal (mesenchymal) stem cells.

Authors:  Ditte C Andersen; Angela Kortesidis; Andrew C W Zannettino; Irina Kratchmarova; Li Chen; Ole N Jensen; Børge Teisner; Stan Gronthos; Charlotte H Jensen; Moustapha Kassem
Journal:  Mol Cells       Date:  2011-05-23       Impact factor: 5.034

6.  The novel bone alkaline phosphatase B1x isoform in children with kidney disease.

Authors:  Diana Swolin-Eide; Sverker Hansson; Lasse Larsson; Per Magnusson
Journal:  Pediatr Nephrol       Date:  2006-08-24       Impact factor: 3.714

7.  Isolation, characterization and investigation of differentiation potential of human periodontal ligament cells and dental follicle progenitor cells and their response to BMP-7 in vitro.

Authors:  Yahya Açil; Fan Yang; Aydin Gulses; Mustafa Ayna; Jörg Wiltfang; Matthias Gierloff
Journal:  Odontology       Date:  2015-03-11       Impact factor: 2.634

8.  ALCAM: Basis Sequence: Mouse.

Authors:  Amanda G Hansen; Guido W Swart; Andries Zijlstra
Journal:  AFCS Nat Mol Pages       Date:  2011

9.  Relation between in vitro and in vivo osteogenic potential of cultured human bone marrow stromal cells.

Authors:  S C Mendes; J M Tibbe; M Veenhof; S Both; F C Oner; C A van Blitterswijk; J D de Bruijn
Journal:  J Mater Sci Mater Med       Date:  2004-10       Impact factor: 3.896

10.  The CD34-like protein PODXL and alpha6-integrin (CD49f) identify early progenitor MSCs with increased clonogenicity and migration to infarcted heart in mice.

Authors:  Ryang Hwa Lee; Min Jeong Seo; Andrey A Pulin; Carl A Gregory; Joni Ylostalo; Darwin J Prockop
Journal:  Blood       Date:  2008-09-25       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.